2022 Top 500 ranking: 15
Akin to science fiction narratives, a patient’s own immune cells could now be clinically harvested and sent to laboratories to be genetically engineered to recognise specific antigens, before they are enlarged and infused back into the body as highly effective cancer-killing agents.
You are not logged in, Sign in or register to request access.
Please note: If you had prior access to this content you may need to sign in again.
Non-asset management investment service providers are able to purchase a subscription for access to premium content such as:
Get access to premium content subscribe today